DDDRX
Price
$15.81
Change
+$0.03 (+0.19%)
Updated
Aug 27 closing price
Net Assets
842.12M
RLBCX
Price
$37.34
Change
+$0.06 (+0.16%)
Updated
Aug 27 closing price
Net Assets
255.46B
Interact to see
Advertisement

DDDRX vs RLBCX

Header iconDDDRX vs RLBCX Comparison
Open Charts DDDRX vs RLBCXBanner chart's image
Macquarie Wealth Builder R
Price$15.81
Change+$0.03 (+0.19%)
VolumeN/A
Net Assets842.12M
American Funds American Balanced R3
Price$37.34
Change+$0.06 (+0.16%)
VolumeN/A
Net Assets255.46B
DDDRX vs RLBCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DDDRX vs. RLBCX commentary
Aug 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DDDRX is a StrongBuy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 255B vs. DDDRX (842M). RLBCX pays higher dividends than DDDRX: RLBCX (1.56) vs DDDRX (1.21). DDDRX was incepted earlier than RLBCX: DDDRX (22 years) vs RLBCX (23 years). DDDRX (1.34) is less costly to investors than RLBCX (0.89). DDDRX is a more actively managed with annual turnover of: 66.00 vs. RLBCX (44.00). DDDRX has a lower initial minimum investment than RLBCX: DDDRX (0) vs RLBCX (250). RLBCX annual gain was more profitable for investors over the last year : 6.92 vs. DDDRX (3.22). RLBCX return over 5 years is better than : 35.08 vs. DDDRX (28.29).
DDDRXRLBCXDDDRX / RLBCX
Total Expense Ratio1.310.89147%
Annual Report Gross Expense Ratio1.340.89151%
Fund Existence22 years23 years-
Gain YTD8.2969.97983%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets842M255B0%
Annual Yield % from dividends1.211.5678%
Returns for 1 year3.226.9247%
Returns for 3 years16.9033.4051%
Returns for 5 years28.2935.0881%
Returns for 10 years39.7769.3157%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNA49.330.46
+0.94%
CNA Financial Corp
SLXN7.260.06
+0.83%
Silexion Therapeutics Corp
IQ2.360.01
+0.43%
iQIYI
NAUT0.70N/A
-0.50%
Nautilus Biotechnolgy
EVTL4.96-0.06
-1.20%
Vertical Aerospace Ltd